| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| nsclc stage 4 | 0.01 | 0.2 | 8139 | 10 | 13 |
| nsclc | 0.56 | 0.9 | 4995 | 79 | 5 |
| stage | 0.81 | 0.4 | 3176 | 55 | 5 |
| 4 | 0.11 | 0.2 | 2337 | 47 | 1 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| nsclc stage 4 | 1.79 | 0.6 | 8700 | 51 |
| nsclc stage 4 life expectancy | 0.04 | 1 | 1162 | 41 |
| nsclc stage 4 clinical trials | 0.31 | 0.4 | 2195 | 64 |
| nsclc stage 4 treatment | 1.33 | 0.6 | 6399 | 17 |
| nsclc stage 4 signs | 1.42 | 0.8 | 9042 | 1 |
| nsclc stage 4b prognosis | 0.37 | 0.3 | 5113 | 30 |
| nsclc stage 4 signs of death | 1.31 | 0.2 | 9125 | 46 |
| nsclc stage 4 prognosis | 0.4 | 0.6 | 1021 | 30 |
| nsclc stage 4 lung cancer egfr exon 20 | 0.99 | 1 | 1931 | 37 |
| nsclc stage 4 survival rate | 1.32 | 0.5 | 8236 | 84 |
| nsclc stage 4 icd 10 | 1.49 | 0.7 | 7287 | 8 |
| nsclc stage 4 lung cancer | 0.62 | 0.2 | 2052 | 56 |
| immunotherapy for nsclc stage 4 | 0.02 | 0.6 | 1524 | 32 |
| nsclc adenocarcinoma stage 4 | 0.68 | 0.2 | 7289 | 11 |
| metastatic stage 4 nsclc prognosis | 1.52 | 0.2 | 752 | 79 |
| what is stage 4 nsclc | 1.19 | 1 | 88 | 87 |
| icd 10 code for stage 4 nsclc | 1.3 | 0.4 | 8585 | 36 |
